nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Zoledronate—osteoporosis	0.132	0.164	CbGbCtD
Amprenavir—ABCC1—Conjugated Estrogens—osteoporosis	0.0734	0.0913	CbGbCtD
Amprenavir—CYP2B6—Raloxifene—osteoporosis	0.0487	0.0607	CbGbCtD
Amprenavir—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0471	0.0586	CbGbCtD
Amprenavir—CYP2C9—Estropipate—osteoporosis	0.0386	0.048	CbGbCtD
Amprenavir—CYP2B6—Cholecalciferol—osteoporosis	0.0376	0.0468	CbGbCtD
Amprenavir—CYP2C8—Raloxifene—osteoporosis	0.0369	0.0459	CbGbCtD
Amprenavir—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0357	0.0444	CbGbCtD
Amprenavir—CYP2C8—Cholecalciferol—osteoporosis	0.0285	0.0355	CbGbCtD
Amprenavir—ABCB1—Ethinyl Estradiol—osteoporosis	0.0241	0.03	CbGbCtD
Amprenavir—CYP2C19—Cholecalciferol—osteoporosis	0.0239	0.0298	CbGbCtD
Amprenavir—CYP3A5—Estradiol—osteoporosis	0.0239	0.0297	CbGbCtD
Amprenavir—CYP2C8—Estradiol—osteoporosis	0.023	0.0286	CbGbCtD
Amprenavir—CYP3A4—Estropipate—osteoporosis	0.0224	0.0279	CbGbCtD
Amprenavir—CYP3A4—Calcitriol—osteoporosis	0.0224	0.0279	CbGbCtD
Amprenavir—CYP2C9—Cholecalciferol—osteoporosis	0.0199	0.0247	CbGbCtD
Amprenavir—CYP2C19—Estradiol—osteoporosis	0.0193	0.024	CbGbCtD
Amprenavir—CYP2D6—Cholecalciferol—osteoporosis	0.0182	0.0226	CbGbCtD
Amprenavir—CYP3A4—Ergocalciferol—osteoporosis	0.0179	0.0223	CbGbCtD
Amprenavir—ABCB1—Conjugated Estrogens—osteoporosis	0.0177	0.022	CbGbCtD
Amprenavir—CYP2C9—Estradiol—osteoporosis	0.016	0.0199	CbGbCtD
Amprenavir—ABCB1—Estradiol—osteoporosis	0.0156	0.0194	CbGbCtD
Amprenavir—CYP3A4—Raloxifene—osteoporosis	0.015	0.0186	CbGbCtD
Amprenavir—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0145	0.018	CbGbCtD
Amprenavir—CYP3A4—Cholecalciferol—osteoporosis	0.0116	0.0144	CbGbCtD
Amprenavir—CYP3A4—Conjugated Estrogens—osteoporosis	0.0106	0.0132	CbGbCtD
Amprenavir—CYP3A4—Estradiol—osteoporosis	0.00932	0.0116	CbGbCtD
Amprenavir—Myalgia—Estropipate—osteoporosis	0.00057	0.00306	CcSEcCtD
Amprenavir—Connective tissue disorder—Pamidronate—osteoporosis	0.000567	0.00305	CcSEcCtD
Amprenavir—Paraesthesia—Etidronic acid—osteoporosis	0.000567	0.00304	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000566	0.00304	CcSEcCtD
Amprenavir—Depression—Conjugated Estrogens—osteoporosis	0.000564	0.00303	CcSEcCtD
Amprenavir—Cardiac disorder—Risedronate—osteoporosis	0.000564	0.00303	CcSEcCtD
Amprenavir—Myalgia—Alendronate—osteoporosis	0.000561	0.00301	CcSEcCtD
Amprenavir—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000558	0.00299	CcSEcCtD
Amprenavir—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000555	0.00298	CcSEcCtD
Amprenavir—Discomfort—Alendronate—osteoporosis	0.000554	0.00298	CcSEcCtD
Amprenavir—Myalgia—Raloxifene—osteoporosis	0.000552	0.00296	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000548	0.00294	CcSEcCtD
Amprenavir—Myalgia—Ibandronate—osteoporosis	0.000546	0.00293	CcSEcCtD
Amprenavir—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000546	0.00293	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000543	0.00291	CcSEcCtD
Amprenavir—Liver function test abnormal—Estradiol—osteoporosis	0.000542	0.00291	CcSEcCtD
Amprenavir—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000542	0.00291	CcSEcCtD
Amprenavir—Discomfort—Ibandronate—osteoporosis	0.00054	0.0029	CcSEcCtD
Amprenavir—Cardiac disorder—Pamidronate—osteoporosis	0.000536	0.00288	CcSEcCtD
Amprenavir—Nervous system disorder—Estropipate—osteoporosis	0.000536	0.00287	CcSEcCtD
Amprenavir—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000535	0.00287	CcSEcCtD
Amprenavir—Myalgia—Calcitriol—osteoporosis	0.000535	0.00287	CcSEcCtD
Amprenavir—Mental disorder—Risedronate—osteoporosis	0.000532	0.00286	CcSEcCtD
Amprenavir—Skin disorder—Estropipate—osteoporosis	0.00053	0.00285	CcSEcCtD
Amprenavir—Malnutrition—Risedronate—osteoporosis	0.000529	0.00284	CcSEcCtD
Amprenavir—Discomfort—Calcitriol—osteoporosis	0.000528	0.00284	CcSEcCtD
Amprenavir—Flatulence—Risedronate—osteoporosis	0.000521	0.0028	CcSEcCtD
Amprenavir—Nervous system disorder—Raloxifene—osteoporosis	0.000519	0.00278	CcSEcCtD
Amprenavir—Connective tissue disorder—Zoledronate—osteoporosis	0.000518	0.00278	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000518	0.00278	CcSEcCtD
Amprenavir—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000516	0.00277	CcSEcCtD
Amprenavir—Skin disorder—Raloxifene—osteoporosis	0.000514	0.00276	CcSEcCtD
Amprenavir—Nervous system disorder—Ibandronate—osteoporosis	0.000514	0.00276	CcSEcCtD
Amprenavir—Skin disorder—Ibandronate—osteoporosis	0.000509	0.00273	CcSEcCtD
Amprenavir—Nausea—Ergocalciferol—osteoporosis	0.000504	0.00271	CcSEcCtD
Amprenavir—Malnutrition—Pamidronate—osteoporosis	0.000503	0.0027	CcSEcCtD
Amprenavir—Abdominal pain—Etidronic acid—osteoporosis	0.000499	0.00268	CcSEcCtD
Amprenavir—Skin disorder—Calcitriol—osteoporosis	0.000498	0.00267	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000498	0.00267	CcSEcCtD
Amprenavir—Angioedema—Ethinyl Estradiol—osteoporosis	0.000496	0.00266	CcSEcCtD
Amprenavir—Paraesthesia—Estropipate—osteoporosis	0.00049	0.00263	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00049	0.00263	CcSEcCtD
Amprenavir—Cardiac disorder—Zoledronate—osteoporosis	0.00049	0.00263	CcSEcCtD
Amprenavir—Anorexia—Calcitriol—osteoporosis	0.000489	0.00262	CcSEcCtD
Amprenavir—Abdominal discomfort—Estradiol—osteoporosis	0.000487	0.00261	CcSEcCtD
Amprenavir—Angioedema—Risedronate—osteoporosis	0.000483	0.00259	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000482	0.00259	CcSEcCtD
Amprenavir—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00048	0.00258	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000477	0.00256	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Estropipate—osteoporosis	0.000471	0.00253	CcSEcCtD
Amprenavir—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000471	0.00253	CcSEcCtD
Amprenavir—Fatigue—Estropipate—osteoporosis	0.000471	0.00253	CcSEcCtD
Amprenavir—Paraesthesia—Ibandronate—osteoporosis	0.00047	0.00252	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000467	0.00251	CcSEcCtD
Amprenavir—Mental disorder—Zoledronate—osteoporosis	0.000462	0.00248	CcSEcCtD
Amprenavir—Angioedema—Pamidronate—osteoporosis	0.000459	0.00247	CcSEcCtD
Amprenavir—Malnutrition—Zoledronate—osteoporosis	0.000459	0.00246	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000459	0.00246	CcSEcCtD
Amprenavir—Hyperglycaemia—Estradiol—osteoporosis	0.000458	0.00246	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000457	0.00245	CcSEcCtD
Amprenavir—Discomfort—Ethinyl Estradiol—osteoporosis	0.000456	0.00245	CcSEcCtD
Amprenavir—Decreased appetite—Ibandronate—osteoporosis	0.000455	0.00244	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000452	0.00243	CcSEcCtD
Amprenavir—Depression—Estradiol—osteoporosis	0.000451	0.00242	CcSEcCtD
Amprenavir—Fatigue—Ibandronate—osteoporosis	0.000451	0.00242	CcSEcCtD
Amprenavir—Myalgia—Risedronate—osteoporosis	0.00045	0.00242	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000447	0.0024	CcSEcCtD
Amprenavir—Pruritus—Etidronic acid—osteoporosis	0.000447	0.0024	CcSEcCtD
Amprenavir—Gastrointestinal pain—Estropipate—osteoporosis	0.000447	0.0024	CcSEcCtD
Amprenavir—Acute coronary syndrome—Estradiol—osteoporosis	0.000446	0.0024	CcSEcCtD
Amprenavir—Decreased appetite—Calcitriol—osteoporosis	0.000446	0.00239	CcSEcCtD
Amprenavir—Mental disorder—Conjugated Estrogens—osteoporosis	0.000445	0.00239	CcSEcCtD
Amprenavir—Myocardial infarction—Estradiol—osteoporosis	0.000444	0.00238	CcSEcCtD
Amprenavir—Malnutrition—Conjugated Estrogens—osteoporosis	0.000442	0.00237	CcSEcCtD
Amprenavir—Gastrointestinal pain—Alendronate—osteoporosis	0.00044	0.00236	CcSEcCtD
Amprenavir—Flatulence—Conjugated Estrogens—osteoporosis	0.000436	0.00234	CcSEcCtD
Amprenavir—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000434	0.00233	CcSEcCtD
Amprenavir—Gastrointestinal pain—Raloxifene—osteoporosis	0.000433	0.00232	CcSEcCtD
Amprenavir—Diarrhoea—Etidronic acid—osteoporosis	0.000432	0.00232	CcSEcCtD
Amprenavir—Abdominal pain—Estropipate—osteoporosis	0.000432	0.00232	CcSEcCtD
Amprenavir—Tremor—Zoledronate—osteoporosis	0.00043	0.00231	CcSEcCtD
Amprenavir—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00043	0.00231	CcSEcCtD
Amprenavir—Hepatobiliary disease—Estradiol—osteoporosis	0.000428	0.0023	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ibandronate—osteoporosis	0.000428	0.0023	CcSEcCtD
Amprenavir—Myalgia—Pamidronate—osteoporosis	0.000428	0.0023	CcSEcCtD
Amprenavir—Abdominal pain—Alendronate—osteoporosis	0.000425	0.00228	CcSEcCtD
Amprenavir—Nervous system disorder—Risedronate—osteoporosis	0.000423	0.00227	CcSEcCtD
Amprenavir—Discomfort—Pamidronate—osteoporosis	0.000423	0.00227	CcSEcCtD
Amprenavir—Angioedema—Zoledronate—osteoporosis	0.00042	0.00225	CcSEcCtD
Amprenavir—Skin disorder—Risedronate—osteoporosis	0.000419	0.00225	CcSEcCtD
Amprenavir—Gastrointestinal pain—Calcitriol—osteoporosis	0.000419	0.00225	CcSEcCtD
Amprenavir—Abdominal pain—Raloxifene—osteoporosis	0.000418	0.00224	CcSEcCtD
Amprenavir—Abdominal pain—Ibandronate—osteoporosis	0.000414	0.00222	CcSEcCtD
Amprenavir—Abdominal pain—Calcitriol—osteoporosis	0.000405	0.00218	CcSEcCtD
Amprenavir—Angioedema—Conjugated Estrogens—osteoporosis	0.000404	0.00217	CcSEcCtD
Amprenavir—Nervous system disorder—Pamidronate—osteoporosis	0.000402	0.00216	CcSEcCtD
Amprenavir—Vomiting—Etidronic acid—osteoporosis	0.000401	0.00215	CcSEcCtD
Amprenavir—Connective tissue disorder—Estradiol—osteoporosis	0.000399	0.00214	CcSEcCtD
Amprenavir—Rash—Etidronic acid—osteoporosis	0.000398	0.00214	CcSEcCtD
Amprenavir—Dermatitis—Etidronic acid—osteoporosis	0.000398	0.00213	CcSEcCtD
Amprenavir—Headache—Etidronic acid—osteoporosis	0.000395	0.00212	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000393	0.00211	CcSEcCtD
Amprenavir—Asthenia—Estropipate—osteoporosis	0.000392	0.0021	CcSEcCtD
Amprenavir—Anorexia—Pamidronate—osteoporosis	0.000391	0.0021	CcSEcCtD
Amprenavir—Myalgia—Zoledronate—osteoporosis	0.000391	0.0021	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000388	0.00208	CcSEcCtD
Amprenavir—Paraesthesia—Risedronate—osteoporosis	0.000388	0.00208	CcSEcCtD
Amprenavir—Pruritus—Estropipate—osteoporosis	0.000386	0.00207	CcSEcCtD
Amprenavir—Discomfort—Zoledronate—osteoporosis	0.000386	0.00207	CcSEcCtD
Amprenavir—Asthenia—Alendronate—osteoporosis	0.000386	0.00207	CcSEcCtD
Amprenavir—Erythema multiforme—Estradiol—osteoporosis	0.000384	0.00206	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000382	0.00205	CcSEcCtD
Amprenavir—Fatigue—Ethinyl Estradiol—osteoporosis	0.000382	0.00205	CcSEcCtD
Amprenavir—Pruritus—Alendronate—osteoporosis	0.000381	0.00204	CcSEcCtD
Amprenavir—Cardiac disorder—Estradiol—osteoporosis	0.000377	0.00202	CcSEcCtD
Amprenavir—Myalgia—Conjugated Estrogens—osteoporosis	0.000376	0.00202	CcSEcCtD
Amprenavir—Asthenia—Ibandronate—osteoporosis	0.000376	0.00202	CcSEcCtD
Amprenavir—Nausea—Etidronic acid—osteoporosis	0.000375	0.00201	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000374	0.00201	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000374	0.00201	CcSEcCtD
Amprenavir—Diarrhoea—Estropipate—osteoporosis	0.000374	0.00201	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Risedronate—osteoporosis	0.000373	0.002	CcSEcCtD
Amprenavir—Fatigue—Risedronate—osteoporosis	0.000372	0.002	CcSEcCtD
Amprenavir—Pruritus—Ibandronate—osteoporosis	0.00037	0.00199	CcSEcCtD
Amprenavir—Paraesthesia—Pamidronate—osteoporosis	0.000368	0.00198	CcSEcCtD
Amprenavir—Diarrhoea—Alendronate—osteoporosis	0.000368	0.00198	CcSEcCtD
Amprenavir—Asthenia—Calcitriol—osteoporosis	0.000368	0.00197	CcSEcCtD
Amprenavir—Nervous system disorder—Zoledronate—osteoporosis	0.000368	0.00197	CcSEcCtD
Amprenavir—Skin disorder—Zoledronate—osteoporosis	0.000364	0.00195	CcSEcCtD
Amprenavir—Pruritus—Calcitriol—osteoporosis	0.000363	0.00195	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000362	0.00194	CcSEcCtD
Amprenavir—Diarrhoea—Raloxifene—osteoporosis	0.000362	0.00194	CcSEcCtD
Amprenavir—Diarrhoea—Ibandronate—osteoporosis	0.000358	0.00192	CcSEcCtD
Amprenavir—Anorexia—Zoledronate—osteoporosis	0.000357	0.00192	CcSEcCtD
Amprenavir—Decreased appetite—Pamidronate—osteoporosis	0.000357	0.00191	CcSEcCtD
Amprenavir—Mental disorder—Estradiol—osteoporosis	0.000356	0.00191	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000354	0.0019	CcSEcCtD
Amprenavir—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000354	0.0019	CcSEcCtD
Amprenavir—Malnutrition—Estradiol—osteoporosis	0.000354	0.0019	CcSEcCtD
Amprenavir—Fatigue—Pamidronate—osteoporosis	0.000354	0.0019	CcSEcCtD
Amprenavir—Gastrointestinal pain—Risedronate—osteoporosis	0.000353	0.00189	CcSEcCtD
Amprenavir—Diarrhoea—Calcitriol—osteoporosis	0.000351	0.00188	CcSEcCtD
Amprenavir—Skin disorder—Conjugated Estrogens—osteoporosis	0.00035	0.00188	CcSEcCtD
Amprenavir—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00035	0.00188	CcSEcCtD
Amprenavir—Flatulence—Estradiol—osteoporosis	0.000349	0.00187	CcSEcCtD
Amprenavir—Vomiting—Estropipate—osteoporosis	0.000347	0.00186	CcSEcCtD
Amprenavir—Rash—Estropipate—osteoporosis	0.000344	0.00185	CcSEcCtD
Amprenavir—Dermatitis—Estropipate—osteoporosis	0.000344	0.00185	CcSEcCtD
Amprenavir—Anorexia—Conjugated Estrogens—osteoporosis	0.000344	0.00185	CcSEcCtD
Amprenavir—Headache—Estropipate—osteoporosis	0.000342	0.00184	CcSEcCtD
Amprenavir—Vomiting—Alendronate—osteoporosis	0.000342	0.00184	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000341	0.00183	CcSEcCtD
Amprenavir—Abdominal pain—Risedronate—osteoporosis	0.000341	0.00183	CcSEcCtD
Amprenavir—Rash—Alendronate—osteoporosis	0.000339	0.00182	CcSEcCtD
Amprenavir—Dermatitis—Alendronate—osteoporosis	0.000339	0.00182	CcSEcCtD
Amprenavir—Headache—Alendronate—osteoporosis	0.000337	0.00181	CcSEcCtD
Amprenavir—Paraesthesia—Zoledronate—osteoporosis	0.000336	0.00181	CcSEcCtD
Amprenavir—Vomiting—Raloxifene—osteoporosis	0.000336	0.00181	CcSEcCtD
Amprenavir—Gastrointestinal pain—Pamidronate—osteoporosis	0.000335	0.0018	CcSEcCtD
Amprenavir—Rash—Raloxifene—osteoporosis	0.000334	0.00179	CcSEcCtD
Amprenavir—Dermatitis—Raloxifene—osteoporosis	0.000333	0.00179	CcSEcCtD
Amprenavir—Vomiting—Ibandronate—osteoporosis	0.000333	0.00179	CcSEcCtD
Amprenavir—Tremor—Estradiol—osteoporosis	0.000332	0.00178	CcSEcCtD
Amprenavir—Headache—Raloxifene—osteoporosis	0.000331	0.00178	CcSEcCtD
Amprenavir—Rash—Ibandronate—osteoporosis	0.00033	0.00177	CcSEcCtD
Amprenavir—Dermatitis—Ibandronate—osteoporosis	0.00033	0.00177	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000329	0.00176	CcSEcCtD
Amprenavir—Headache—Ibandronate—osteoporosis	0.000328	0.00176	CcSEcCtD
Amprenavir—Vomiting—Calcitriol—osteoporosis	0.000326	0.00175	CcSEcCtD
Amprenavir—Decreased appetite—Zoledronate—osteoporosis	0.000326	0.00175	CcSEcCtD
Amprenavir—Nausea—Estropipate—osteoporosis	0.000324	0.00174	CcSEcCtD
Amprenavir—Abdominal pain—Pamidronate—osteoporosis	0.000324	0.00174	CcSEcCtD
Amprenavir—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000324	0.00174	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000324	0.00174	CcSEcCtD
Amprenavir—Angioedema—Estradiol—osteoporosis	0.000323	0.00174	CcSEcCtD
Amprenavir—Rash—Calcitriol—osteoporosis	0.000323	0.00173	CcSEcCtD
Amprenavir—Fatigue—Zoledronate—osteoporosis	0.000323	0.00173	CcSEcCtD
Amprenavir—Dermatitis—Calcitriol—osteoporosis	0.000323	0.00173	CcSEcCtD
Amprenavir—Headache—Calcitriol—osteoporosis	0.000321	0.00172	CcSEcCtD
Amprenavir—Nausea—Alendronate—osteoporosis	0.000319	0.00171	CcSEcCtD
Amprenavir—Asthenia—Ethinyl Estradiol—osteoporosis	0.000318	0.0017	CcSEcCtD
Amprenavir—Nausea—Raloxifene—osteoporosis	0.000314	0.00169	CcSEcCtD
Amprenavir—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000314	0.00168	CcSEcCtD
Amprenavir—Pruritus—Ethinyl Estradiol—osteoporosis	0.000313	0.00168	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000312	0.00167	CcSEcCtD
Amprenavir—Fatigue—Conjugated Estrogens—osteoporosis	0.000311	0.00167	CcSEcCtD
Amprenavir—Nausea—Ibandronate—osteoporosis	0.000311	0.00167	CcSEcCtD
Amprenavir—Asthenia—Risedronate—osteoporosis	0.00031	0.00166	CcSEcCtD
Amprenavir—Gastrointestinal pain—Zoledronate—osteoporosis	0.000306	0.00164	CcSEcCtD
Amprenavir—Pruritus—Risedronate—osteoporosis	0.000305	0.00164	CcSEcCtD
Amprenavir—Nausea—Calcitriol—osteoporosis	0.000304	0.00163	CcSEcCtD
Amprenavir—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000303	0.00163	CcSEcCtD
Amprenavir—Myalgia—Estradiol—osteoporosis	0.000301	0.00162	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000299	0.00161	CcSEcCtD
Amprenavir—Discomfort—Estradiol—osteoporosis	0.000298	0.0016	CcSEcCtD
Amprenavir—Abdominal pain—Zoledronate—osteoporosis	0.000296	0.00159	CcSEcCtD
Amprenavir—Diarrhoea—Risedronate—osteoporosis	0.000295	0.00158	CcSEcCtD
Amprenavir—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000295	0.00158	CcSEcCtD
Amprenavir—Asthenia—Pamidronate—osteoporosis	0.000294	0.00158	CcSEcCtD
Amprenavir—Pruritus—Pamidronate—osteoporosis	0.00029	0.00156	CcSEcCtD
Amprenavir—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000285	0.00153	CcSEcCtD
Amprenavir—Nervous system disorder—Estradiol—osteoporosis	0.000283	0.00152	CcSEcCtD
Amprenavir—Vomiting—Ethinyl Estradiol—osteoporosis	0.000281	0.00151	CcSEcCtD
Amprenavir—Diarrhoea—Pamidronate—osteoporosis	0.000281	0.00151	CcSEcCtD
Amprenavir—Skin disorder—Estradiol—osteoporosis	0.000281	0.00151	CcSEcCtD
Amprenavir—Rash—Ethinyl Estradiol—osteoporosis	0.000279	0.0015	CcSEcCtD
Amprenavir—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000279	0.0015	CcSEcCtD
Amprenavir—Headache—Ethinyl Estradiol—osteoporosis	0.000277	0.00149	CcSEcCtD
Amprenavir—Vomiting—Risedronate—osteoporosis	0.000274	0.00147	CcSEcCtD
Amprenavir—Rash—Risedronate—osteoporosis	0.000272	0.00146	CcSEcCtD
Amprenavir—Dermatitis—Risedronate—osteoporosis	0.000272	0.00146	CcSEcCtD
Amprenavir—Headache—Risedronate—osteoporosis	0.00027	0.00145	CcSEcCtD
Amprenavir—Asthenia—Zoledronate—osteoporosis	0.000269	0.00144	CcSEcCtD
Amprenavir—Pruritus—Zoledronate—osteoporosis	0.000265	0.00142	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000263	0.00141	CcSEcCtD
Amprenavir—Nausea—Ethinyl Estradiol—osteoporosis	0.000263	0.00141	CcSEcCtD
Amprenavir—Vomiting—Pamidronate—osteoporosis	0.000261	0.0014	CcSEcCtD
Amprenavir—Paraesthesia—Estradiol—osteoporosis	0.000259	0.00139	CcSEcCtD
Amprenavir—Asthenia—Conjugated Estrogens—osteoporosis	0.000259	0.00139	CcSEcCtD
Amprenavir—Rash—Pamidronate—osteoporosis	0.000259	0.00139	CcSEcCtD
Amprenavir—Dermatitis—Pamidronate—osteoporosis	0.000258	0.00139	CcSEcCtD
Amprenavir—Headache—Pamidronate—osteoporosis	0.000257	0.00138	CcSEcCtD
Amprenavir—Diarrhoea—Zoledronate—osteoporosis	0.000256	0.00138	CcSEcCtD
Amprenavir—Nausea—Risedronate—osteoporosis	0.000256	0.00138	CcSEcCtD
Amprenavir—Pruritus—Conjugated Estrogens—osteoporosis	0.000255	0.00137	CcSEcCtD
Amprenavir—Decreased appetite—Estradiol—osteoporosis	0.000251	0.00135	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Estradiol—osteoporosis	0.000249	0.00134	CcSEcCtD
Amprenavir—Fatigue—Estradiol—osteoporosis	0.000249	0.00134	CcSEcCtD
Amprenavir—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000247	0.00133	CcSEcCtD
Amprenavir—Nausea—Pamidronate—osteoporosis	0.000244	0.00131	CcSEcCtD
Amprenavir—Vomiting—Zoledronate—osteoporosis	0.000238	0.00128	CcSEcCtD
Amprenavir—Rash—Zoledronate—osteoporosis	0.000236	0.00127	CcSEcCtD
Amprenavir—Gastrointestinal pain—Estradiol—osteoporosis	0.000236	0.00127	CcSEcCtD
Amprenavir—Dermatitis—Zoledronate—osteoporosis	0.000236	0.00127	CcSEcCtD
Amprenavir—Headache—Zoledronate—osteoporosis	0.000235	0.00126	CcSEcCtD
Amprenavir—Vomiting—Conjugated Estrogens—osteoporosis	0.000229	0.00123	CcSEcCtD
Amprenavir—Abdominal pain—Estradiol—osteoporosis	0.000228	0.00123	CcSEcCtD
Amprenavir—Rash—Conjugated Estrogens—osteoporosis	0.000228	0.00122	CcSEcCtD
Amprenavir—Dermatitis—Conjugated Estrogens—osteoporosis	0.000227	0.00122	CcSEcCtD
Amprenavir—Headache—Conjugated Estrogens—osteoporosis	0.000226	0.00121	CcSEcCtD
Amprenavir—Nausea—Zoledronate—osteoporosis	0.000223	0.00119	CcSEcCtD
Amprenavir—Nausea—Conjugated Estrogens—osteoporosis	0.000214	0.00115	CcSEcCtD
Amprenavir—Asthenia—Estradiol—osteoporosis	0.000207	0.00111	CcSEcCtD
Amprenavir—Pruritus—Estradiol—osteoporosis	0.000204	0.0011	CcSEcCtD
Amprenavir—Diarrhoea—Estradiol—osteoporosis	0.000198	0.00106	CcSEcCtD
Amprenavir—Vomiting—Estradiol—osteoporosis	0.000184	0.000986	CcSEcCtD
Amprenavir—Rash—Estradiol—osteoporosis	0.000182	0.000977	CcSEcCtD
Amprenavir—Dermatitis—Estradiol—osteoporosis	0.000182	0.000976	CcSEcCtD
Amprenavir—Headache—Estradiol—osteoporosis	0.000181	0.000971	CcSEcCtD
Amprenavir—Nausea—Estradiol—osteoporosis	0.000172	0.000921	CcSEcCtD
Amprenavir—CYP3A5—Metabolism—GPD2—osteoporosis	1.53e-05	0.00151	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PGLS—osteoporosis	1.53e-05	0.00151	CbGpPWpGaD
Amprenavir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.49e-05	0.00148	CbGpPWpGaD
Amprenavir—ABCC1—Disease—P4HB—osteoporosis	1.49e-05	0.00148	CbGpPWpGaD
Amprenavir—CYP2C8—Biological oxidations—POMC—osteoporosis	1.48e-05	0.00146	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP27A1—osteoporosis	1.47e-05	0.00145	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.46e-05	0.00145	CbGpPWpGaD
Amprenavir—ABCC1—Disease—GAPDH—osteoporosis	1.46e-05	0.00145	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ATIC—osteoporosis	1.43e-05	0.00142	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PNP—osteoporosis	1.43e-05	0.00142	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ACP5—osteoporosis	1.43e-05	0.00141	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.41e-05	0.0014	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ATIC—osteoporosis	1.4e-05	0.00138	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PNP—osteoporosis	1.4e-05	0.00138	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—FDPS—osteoporosis	1.4e-05	0.00138	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PKM—osteoporosis	1.4e-05	0.00138	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NFATC1—osteoporosis	1.39e-05	0.00138	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.38e-05	0.00137	CbGpPWpGaD
Amprenavir—ABCC1—Disease—DKK1—osteoporosis	1.38e-05	0.00137	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.37e-05	0.00135	CbGpPWpGaD
Amprenavir—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.34e-05	0.00133	CbGpPWpGaD
Amprenavir—ABCC1—Disease—WNT1—osteoporosis	1.33e-05	0.00132	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—TPI1—osteoporosis	1.33e-05	0.00131	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PGLS—osteoporosis	1.32e-05	0.00131	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPD2—osteoporosis	1.32e-05	0.00131	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.32e-05	0.00131	CbGpPWpGaD
Amprenavir—CYP2C19—Biological oxidations—POMC—osteoporosis	1.32e-05	0.00131	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.32e-05	0.0013	CbGpPWpGaD
Amprenavir—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.3e-05	0.00129	CbGpPWpGaD
Amprenavir—ABCB1—Allograft Rejection—TNF—osteoporosis	1.29e-05	0.00128	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGA—osteoporosis	1.29e-05	0.00128	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—P4HB—osteoporosis	1.25e-05	0.00124	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—FDPS—osteoporosis	1.25e-05	0.00123	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PKM—osteoporosis	1.25e-05	0.00123	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.25e-05	0.00123	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GAPDH—osteoporosis	1.22e-05	0.00121	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—FDPS—osteoporosis	1.22e-05	0.0012	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PKM—osteoporosis	1.22e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—OXCT1—osteoporosis	1.21e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CA2—osteoporosis	1.21e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2D6—Biological oxidations—POMC—osteoporosis	1.21e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ATIC—osteoporosis	1.21e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PNP—osteoporosis	1.21e-05	0.0012	CbGpPWpGaD
Amprenavir—CYP2C9—Biological oxidations—POMC—osteoporosis	1.2e-05	0.00119	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—RAP1A—osteoporosis	1.19e-05	0.00118	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—OXCT1—osteoporosis	1.19e-05	0.00118	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CA2—osteoporosis	1.19e-05	0.00118	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MGLL—osteoporosis	1.18e-05	0.00117	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPD2—osteoporosis	1.18e-05	0.00117	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PGLS—osteoporosis	1.18e-05	0.00117	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MGLL—osteoporosis	1.16e-05	0.00115	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPD2—osteoporosis	1.15e-05	0.00114	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PGLS—osteoporosis	1.15e-05	0.00114	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ENO1—osteoporosis	1.15e-05	0.00114	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PKM—osteoporosis	1.15e-05	0.00113	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—FDPS—osteoporosis	1.15e-05	0.00113	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.14e-05	0.00113	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—FDPS—osteoporosis	1.14e-05	0.00112	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PKM—osteoporosis	1.14e-05	0.00112	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PSMA2—osteoporosis	1.13e-05	0.00112	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PSMA5—osteoporosis	1.13e-05	0.00112	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PGLS—osteoporosis	1.09e-05	0.00108	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPD2—osteoporosis	1.09e-05	0.00108	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ATIC—osteoporosis	1.08e-05	0.00107	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PNP—osteoporosis	1.08e-05	0.00107	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPD2—osteoporosis	1.08e-05	0.00107	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PGLS—osteoporosis	1.08e-05	0.00107	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CALCA—osteoporosis	1.06e-05	0.00105	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PNP—osteoporosis	1.05e-05	0.00104	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ATIC—osteoporosis	1.05e-05	0.00104	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.04e-05	0.00103	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—OXCT1—osteoporosis	1.03e-05	0.00102	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CA2—osteoporosis	1.03e-05	0.00102	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—IDH2—osteoporosis	1.01e-05	0.000997	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MGLL—osteoporosis	1e-05	0.000993	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ATIC—osteoporosis	9.93e-06	0.000983	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PNP—osteoporosis	9.93e-06	0.000983	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ATIC—osteoporosis	9.85e-06	0.000975	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PNP—osteoporosis	9.85e-06	0.000975	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—IDH2—osteoporosis	9.84e-06	0.000974	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ENO1—osteoporosis	9.64e-06	0.000955	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KL—osteoporosis	9.6e-06	0.000951	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PSMA5—osteoporosis	9.5e-06	0.000941	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PSMA2—osteoporosis	9.5e-06	0.000941	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP27A1—osteoporosis	9.47e-06	0.000937	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.45e-06	0.000936	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP27A1—osteoporosis	9.25e-06	0.000916	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ACP5—osteoporosis	9.21e-06	0.000912	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—OXCT1—osteoporosis	9.18e-06	0.000909	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CA2—osteoporosis	9.18e-06	0.000909	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ACP5—osteoporosis	9e-06	0.000891	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CA2—osteoporosis	8.96e-06	0.000887	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—OXCT1—osteoporosis	8.96e-06	0.000887	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MGLL—osteoporosis	8.95e-06	0.000886	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MGLL—osteoporosis	8.73e-06	0.000865	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—TPI1—osteoporosis	8.56e-06	0.000848	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—IDH2—osteoporosis	8.52e-06	0.000844	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CA2—osteoporosis	8.44e-06	0.000836	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—OXCT1—osteoporosis	8.44e-06	0.000836	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.44e-06	0.000835	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—OXCT1—osteoporosis	8.37e-06	0.000829	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CA2—osteoporosis	8.37e-06	0.000829	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—TPI1—osteoporosis	8.37e-06	0.000829	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MGLL—osteoporosis	8.23e-06	0.000815	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MGLL—osteoporosis	8.16e-06	0.000808	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—P4HB—osteoporosis	8.05e-06	0.000797	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP27A1—osteoporosis	8.01e-06	0.000794	CbGpPWpGaD
Amprenavir—CYP3A4—Biological oxidations—POMC—osteoporosis	7.94e-06	0.000786	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GAPDH—osteoporosis	7.9e-06	0.000782	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—P4HB—osteoporosis	7.87e-06	0.000779	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ACP5—osteoporosis	7.8e-06	0.000772	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GAPDH—osteoporosis	7.72e-06	0.000765	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—CYP19A1—osteoporosis	7.71e-06	0.000763	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.7e-06	0.000762	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—RAP1A—osteoporosis	7.69e-06	0.000762	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.69e-06	0.000762	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—IDH2—osteoporosis	7.61e-06	0.000753	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ADCY5—osteoporosis	7.52e-06	0.000745	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—RAP1A—osteoporosis	7.52e-06	0.000745	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PKM—osteoporosis	7.49e-06	0.000742	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—FDPS—osteoporosis	7.49e-06	0.000742	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—IDH2—osteoporosis	7.43e-06	0.000735	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TPI1—osteoporosis	7.25e-06	0.000718	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP27A1—osteoporosis	7.15e-06	0.000708	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PGLS—osteoporosis	7.1e-06	0.000703	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPD2—osteoporosis	7.1e-06	0.000703	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—IDH2—osteoporosis	7e-06	0.000693	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP27A1—osteoporosis	6.98e-06	0.000691	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ACP5—osteoporosis	6.96e-06	0.000689	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—IDH2—osteoporosis	6.94e-06	0.000687	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MTHFR—osteoporosis	6.92e-06	0.000685	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.87e-06	0.00068	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.85e-06	0.000678	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.83e-06	0.000677	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—P4HB—osteoporosis	6.81e-06	0.000675	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ACP5—osteoporosis	6.79e-06	0.000673	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GAPDH—osteoporosis	6.69e-06	0.000662	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IRS2—osteoporosis	6.58e-06	0.000652	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP27A1—osteoporosis	6.58e-06	0.000651	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP27A1—osteoporosis	6.52e-06	0.000646	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—RAP1A—osteoporosis	6.51e-06	0.000645	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ATIC—osteoporosis	6.49e-06	0.000643	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PNP—osteoporosis	6.49e-06	0.000643	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TPI1—osteoporosis	6.47e-06	0.000641	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ACP5—osteoporosis	6.4e-06	0.000634	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.4e-06	0.000634	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.38e-06	0.000632	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ACP5—osteoporosis	6.34e-06	0.000628	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TPI1—osteoporosis	6.31e-06	0.000625	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ADCY5—osteoporosis	6.3e-06	0.000624	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—GPX1—osteoporosis	6.28e-06	0.000622	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.26e-06	0.00062	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ENO1—osteoporosis	6.22e-06	0.000616	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PSMA2—osteoporosis	6.13e-06	0.000607	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PSMA5—osteoporosis	6.13e-06	0.000607	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—P4HB—osteoporosis	6.08e-06	0.000602	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ENO1—osteoporosis	6.08e-06	0.000602	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PSMA2—osteoporosis	5.99e-06	0.000593	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PSMA5—osteoporosis	5.99e-06	0.000593	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GAPDH—osteoporosis	5.97e-06	0.000591	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TPI1—osteoporosis	5.95e-06	0.000589	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—P4HB—osteoporosis	5.94e-06	0.000588	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TPI1—osteoporosis	5.9e-06	0.000584	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GAPDH—osteoporosis	5.83e-06	0.000577	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—RAP1A—osteoporosis	5.81e-06	0.000576	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—MTHFR—osteoporosis	5.79e-06	0.000574	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IRS1—osteoporosis	5.74e-06	0.000569	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.68e-06	0.000563	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—RAP1A—osteoporosis	5.67e-06	0.000562	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—P4HB—osteoporosis	5.59e-06	0.000554	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—P4HB—osteoporosis	5.55e-06	0.000549	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—OXCT1—osteoporosis	5.52e-06	0.000547	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CA2—osteoporosis	5.52e-06	0.000547	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GAPDH—osteoporosis	5.49e-06	0.000544	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GAPDH—osteoporosis	5.44e-06	0.000539	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6R—osteoporosis	5.4e-06	0.000534	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MGLL—osteoporosis	5.38e-06	0.000533	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—RAP1A—osteoporosis	5.35e-06	0.00053	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—RAP1A—osteoporosis	5.3e-06	0.000525	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ENO1—osteoporosis	5.27e-06	0.000521	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PSMA5—osteoporosis	5.19e-06	0.000514	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PSMA2—osteoporosis	5.19e-06	0.000514	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.07e-06	0.000502	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP19A1—osteoporosis	4.97e-06	0.000492	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP19A1—osteoporosis	4.86e-06	0.000481	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ENO1—osteoporosis	4.7e-06	0.000465	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—POMC—osteoporosis	4.63e-06	0.000459	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PSMA5—osteoporosis	4.63e-06	0.000459	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PSMA2—osteoporosis	4.63e-06	0.000459	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.62e-06	0.000458	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ENO1—osteoporosis	4.59e-06	0.000454	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH2—osteoporosis	4.57e-06	0.000453	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PSMA2—osteoporosis	4.52e-06	0.000448	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PSMA5—osteoporosis	4.52e-06	0.000448	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ENO1—osteoporosis	4.32e-06	0.000428	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.3e-06	0.000426	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ENO1—osteoporosis	4.29e-06	0.000424	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSMA5—osteoporosis	4.26e-06	0.000422	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PSMA2—osteoporosis	4.26e-06	0.000422	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSMA2—osteoporosis	4.22e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PSMA5—osteoporosis	4.22e-06	0.000418	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP19A1—osteoporosis	4.21e-06	0.000417	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ACP5—osteoporosis	4.18e-06	0.000414	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ADCY5—osteoporosis	4.06e-06	0.000402	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GPX1—osteoporosis	4.05e-06	0.000401	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ADCY5—osteoporosis	3.97e-06	0.000393	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—osteoporosis	3.96e-06	0.000392	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TPI1—osteoporosis	3.89e-06	0.000385	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP19A1—osteoporosis	3.76e-06	0.000372	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—osteoporosis	3.74e-06	0.00037	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP19A1—osteoporosis	3.67e-06	0.000363	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—P4HB—osteoporosis	3.66e-06	0.000362	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—osteoporosis	3.65e-06	0.000362	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GAPDH—osteoporosis	3.59e-06	0.000355	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—RAP1A—osteoporosis	3.5e-06	0.000346	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP19A1—osteoporosis	3.46e-06	0.000342	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ADCY5—osteoporosis	3.44e-06	0.000341	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—osteoporosis	3.43e-06	0.000339	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP19A1—osteoporosis	3.43e-06	0.000339	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—osteoporosis	3.2e-06	0.000317	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—osteoporosis	3.19e-06	0.000316	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—osteoporosis	3.16e-06	0.000313	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ADCY5—osteoporosis	3.07e-06	0.000304	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—osteoporosis	3.06e-06	0.000303	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ADCY5—osteoporosis	3e-06	0.000297	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—POMC—osteoporosis	2.99e-06	0.000296	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—osteoporosis	2.99e-06	0.000296	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—POMC—osteoporosis	2.92e-06	0.000289	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO1—osteoporosis	2.83e-06	0.00028	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ADCY5—osteoporosis	2.82e-06	0.00028	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—osteoporosis	2.82e-06	0.00028	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—osteoporosis	2.81e-06	0.000279	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ADCY5—osteoporosis	2.8e-06	0.000277	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—osteoporosis	2.79e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMA2—osteoporosis	2.78e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PSMA5—osteoporosis	2.78e-06	0.000276	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—osteoporosis	2.76e-06	0.000273	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—osteoporosis	2.6e-06	0.000257	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—osteoporosis	2.57e-06	0.000255	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—POMC—osteoporosis	2.53e-06	0.000251	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—osteoporosis	2.4e-06	0.000238	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.26e-06	0.000224	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—POMC—osteoporosis	2.26e-06	0.000224	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—POMC—osteoporosis	2.2e-06	0.000218	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—POMC—osteoporosis	2.08e-06	0.000206	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—POMC—osteoporosis	2.06e-06	0.000204	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ADCY5—osteoporosis	1.85e-06	0.000183	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—osteoporosis	1.84e-06	0.000182	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—osteoporosis	1.7e-06	0.000168	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—POMC—osteoporosis	1.36e-06	0.000134	CbGpPWpGaD
